BioLineRx Ltd. BLRX
Set alert
1.99 USD -0.03 -1.49%
At close · Oct 30
1.95 -0.04 -2.01%
After hours · Oct 30, 4:00 PM ET
1.95 Day range 1.99
1.98 52-week range 3.78
- YTD
- -28.16%
- 1 year
- -42.32%
- Open
- 1.99
- Prev close
- 2.02
- Mkt cap
- 9.91M
- Vol
- 8.79K
- Avg vol
- 16.94K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.95
- High
- 1.99
- Forward P/E
- -1.06
- Beta
- 0.87
- Short ratio
- 2.39
- Inst. own
- 3.09%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.3624
- 200-d avg
- 0.62615
- 1y target
- 4.57
Financial health
Altman Z-Score
-17.32 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -9.6×
FY 2016 5y median -1.9× FY 2025
P/S 9.6×
FY 2016 5y median 0.6× FY 2025
P/B 0.6×
FY 2016 5y median 1.3× FY 2025
P/FCF -1.4×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -81.3×
FY 2016 5y median -1.9× FY 2025
EV/Sales 15.4×
FY 2016 5y median 0.7× FY 2025
FCF Yield -71.7%
FY 2016 5y median -71.7% FY 2025
Profitability
Gross Margin 36.2%
FY 2016 5y median 23.1% FY 2025
Operating Margin -871.8%
FY 2016 5y median -70.5% FY 2025
Net Margin -99.6%
FY 2016 5y median -31.9% FY 2025
ROE -6.5%
FY 2016 5y median -49.1% FY 2025
ROIC -31.0%
FY 2016 5y median -43.1% FY 2025
ROA -2.9%
FY 2016 5y median -32.7% FY 2025
Growth (YoY)
Revenue -95.9%
FY 2016 FY 2025
Operating Income 49.2%
FY 2016 FY 2025
EPS (diluted) 93.7%
FY 2016 FY 2025
Free Cash Flow 81.4%
FY 2016 FY 2025
Financial Health
Current Ratio 2.0×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 1.8×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -30.7×
FY 2016 5y median -0.1× FY 2025
Interest Coverage -8.0×
FY 2016 5y median -13.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31